speb/financial-data huggingface dataset:
Stock screener scorecard for 3899.HK (annual, report date 2025-12-31)
Altman Z-score: 2.1527708989233583 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 9.57540416995582%
Earnings yield: 1.547201207702159%
Return on net tangible assets: 7.215406384769348%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 8.332718999112165%
Free cash flow margin: 3.0864802482661395%
Revenue growth: 10.900340624651388%
Rule of 40 score: 13.986820872917528
Market cap: 16212429824 (Large Cap ($10B-$200B))
P/E ratio: 1.827602827763496
Debt to equity: 0.2733
Free cash flow (dilution adjusted): 116077857.14285713
Operating income: 204910571.42857143
Net income: 167370142.85714287
Long score: 5 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 4662.T (annual, report date 2026-03-31)
Altman Z-score: 4.656506755227001 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 27.472063817833753%
Earnings yield: 0.09928810199791352%
Return on net tangible assets: 15.305351072398826%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 18.579599935451547%
Free cash flow margin: 6.743990574033874%
Revenue growth: 2.645615791839711%
Rule of 40 score: 9.389606365873584
Market cap: 25224683520 (Large Cap ($10B-$200B))
P/E ratio: 0.06305688999849725
Debt to equity: 0.14150000000000001
Free cash flow (dilution adjusted): 15062099.5995996
Operating income: 18994819.81981982
Net income: 14597015.765765766
Long score: 12 | Short score: 1
Recommendation: Long
Stock screener scorecard for 6357.T (annual, report date 2026-03-31)
Altman Z-score: 2.3769614263078704 (Grey Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 13.929666370836625%
Earnings yield: 0.13747486329378436%
Return on net tangible assets: 10.182250436516775%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 9.873443572333269%
Free cash flow margin: 7.849784535084944%
Revenue growth: 10.566338775351507%
Rule of 40 score: 18.41612331043645
Market cap: 41385111552 (Large Cap ($10B-$200B))
P/E ratio: 0.04845870678391532
Debt to equity: 0.3017
Free cash flow (dilution adjusted): 35884934.93493494
Operating income: 41105630.63063063
Net income: 31920658.158158157
Long score: 9 | Short score: 1
Recommendation: Long
Stock screener scorecard for 6923.T (annual, report date 2026-03-31)
Altman Z-score: 2.7514881368319726 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 8.568623277741859%
Earnings yield: 0.061602593922558214%
Return on net tangible assets: 6.547694422836884%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.742110900812371%
Free cash flow margin: 3.999953708704307%
Revenue growth: -4.760634369810818%
Rule of 40 score: -0.7606806611065111
Market cap: 422637666304 (Mega Cap (>= $200B))
P/E ratio: 0.0744315119497176
Debt to equity: 0.2114
Free cash flow (dilution adjusted): 129742242.24224225
Operating income: 266985735.73573574
Net income: 264508258.25825825
Long score: 5 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for 7480.T (annual, report date 2026-03-31)
Altman Z-score: 4.682708380072707 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 12.404758094705114%
Earnings yield: 0.05125265486560337%
Return on net tangible assets: 11.682878685919833%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.604382232472613%
Free cash flow margin: 3.292321150994277%
Revenue growth: -7.857872744632802%
Rule of 40 score: -4.565551593638525
Market cap: 30864250880 (Large Cap ($10B-$200B))
P/E ratio: 0.08283477275725337
Debt to equity: 0.07519999999999999
Free cash flow (dilution adjusted): 9454773.523523523
Operating income: 12963463.463463463
Net income: 10778897.647647647
Long score: 8 | Short score: 1
Recommendation: Long
Stock screener scorecard for 9158.T (annual, report date 2026-03-31)
Altman Z-score: 1.381780043196728 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 9.913416202314616%
Earnings yield: 0.06023387673455215%
Return on net tangible assets: 12.561403508771932%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.948350037253347%
Free cash flow margin: -1.902378893529336%
Revenue growth: 8.151535514001763%
Rule of 40 score: 6.2491566204724265
Market cap: 22719363072 (Large Cap ($10B-$200B))
P/E ratio: 0.0559810889582823
Debt to equity: 1.5434
Free cash flow (dilution adjusted): -6468968.968968969
Operating income: 36173673.673673674
Net income: 17855355.355355356
Long score: 2 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for AFK.OL (quarterly, report date 2026-03-31)
Altman Z-score: 2.984661980073453 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 6.429489927132447%
Earnings yield: 0.15475178216749172%
Return on net tangible assets: 0.851063829787234%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.432695426532598%
Free cash flow margin: 16.178067318132467%
Revenue growth: -4.392982383655173%
Rule of 40 score: 11.785084934477293
Market cap: 9621931008 (Mid Cap ($2B-$10B))
P/E ratio: 15.769242238410651
Debt to equity: 0.33130000000000004
Free cash flow (dilution adjusted): 15313463.514902363
Operating income: 15416238.43782117
Net income: 3391572.4563206574
Long score: 6 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for BE (quarterly, report date 2026-03-31)
Altman Z-score: 8.341184823567417 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 1.962636768106269%
Earnings yield: 0.13600546567092217%
Return on net tangible assets: 6.606733378985077%
Capitalized R&D asset: 110373550
ROCI (R&D adjusted): 1.885975495323271%
Rosenberg metric: -0.2567768254933887
Free cash flow margin: 0.30663574123831305%
Revenue growth: -3.4241458280559045%
Rule of 40 score: -3.1175100868175916
Market cap: 52590825472 (Large Cap ($10B-$200B))
P/E ratio: 3867.4660988780734
Debt to equity: 3.1148000000000002
Free cash flow (dilution adjusted): 2303000
Operating income: 72190000
Net income: 73691000
Long score: 4 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for C5H.IR (annual, report date 2025-12-31)
Altman Z-score: 4.740387578417226 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 16.161304361997267%
Earnings yield: 11.627754814348744%
Return on net tangible assets: 16.089630899781664%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 15.966790863130697%
Free cash flow margin: 6.540928175345065%
Revenue growth: 24.070834975451508%
Rule of 40 score: 30.611763150796573
Market cap: 1537374848 (Small Cap ($300M-$2B))
P/E ratio: 11.372549019607844
Debt to equity: 0.2772
Free cash flow (dilution adjusted): 72689411.76470588
Operating income: 198336470.5882353
Net income: 156135294.11764705
Long score: 10 | Short score: 1
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for CDZ0.DE (annual, report date 2025-12-31)
Altman Z-score: 2.5979278242517996 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 39.02319333666113%
Earnings yield: 17.759442159345515%
Return on net tangible assets: -84.79325147869731%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.57222032279197%
Free cash flow margin: -3.579300093180951%
Revenue growth: 24.941750690104474%
Rule of 40 score: 21.362450596923523
Market cap: 65809984 (Micro Cap ($50M-$300M))
P/E ratio: 13.823529411764705
Debt to equity: 0.1655
Free cash flow (dilution adjusted): -7501707.6823529415
Operating income: 11506917.270588236
Net income: 6788709.3176470585
Long score: 9 | Short score: 5
Recommendation: Long
Stock screener scorecard for CHEMCON.NS (annual, report date 2026-03-31)
Altman Z-score: 5.669880454800033 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 3.854595727977819%
Earnings yield: 0.03922012956842262%
Return on net tangible assets: 5.388182935312952%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.803868938962276%
Free cash flow margin: 13.482351990112463%
Revenue growth: 4.891875496658141%
Rule of 40 score: 18.374227486770604
Market cap: 6466417664 (Mid Cap ($2B-$10B))
P/E ratio: 0.19969422487381694
Debt to equity: 0.11
Free cash flow (dilution adjusted): 3428868.164476473
Operating income: 1973177.1937261552
Net income: 2500869.012293345
Long score: 6 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for CHEMCON.NS (quarterly, report date 2026-03-31)
Altman Z-score: 5.304792383336462 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 1.1695310779096668%
Earnings yield: 0.011899862825297577%
Return on net tangible assets: 1.989146347546627%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.1541399550986196%
Revenue growth: 25.168643809134362%
Rule of 40 score: 25.168643809134362
Market cap: 6466417664 (Mid Cap ($2B-$10B))
P/E ratio: 0.19969422487381694
Debt to equity: 0.11
Operating income: 598685.8838490886
Net income: 675211.954217889
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for EHL.AX (annual, report date 2025-06-30)
Altman Z-score: 1.2329167927629876 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 12.484713448129902%
Earnings yield: 13.643413377321856%
Return on net tangible assets: 11.51426723595035%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.29301705766782%
Free cash flow margin: 11.714207860404352%
Revenue growth: -6.4144040362325985%
Rule of 40 score: 5.299803824171754
Market cap: 497639744 (Small Cap ($300M-$2B))
P/E ratio: 3.6165577342047928
Debt to equity: 0.4163
Free cash flow (dilution adjusted): 60129411.76470588
Operating income: 86942483.66013072
Net income: 49111111.11111111
Long score: 9 | Short score: 2
Recommendation: Long
Stock screener scorecard for FILATEX.NS (quarterly, report date 2026-03-31)
Altman Z-score: 2.6681724163943104 (Grey Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 3.9186461365130043%
Earnings yield: 0.044891953857350377%
Return on net tangible assets: 3.9608443763734438%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.74151184419892%
Revenue growth: -10.683783549776212%
Rule of 40 score: -10.683783549776212
Market cap: 32784830464 (Large Cap ($10B-$200B))
P/E ratio: 0.09426698351273013
Debt to equity: 0.0998
Operating income: 7077151.335311573
Net income: 4247562.526494278
Long score: 3 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for FILATEX.NS (annual, report date 2026-03-31)
Altman Z-score: 4.223315754666155 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 15.774927236879169%
Earnings yield: 0.18071733985432015%
Return on net tangible assets: 4.548178730771793%
Capitalized R&D asset: 73649.47835471878
ROCI (R&D adjusted): 15.016677370952594%
Free cash flow margin: 1.2462384509628606%
Revenue growth: -11.300667551981297%
Rule of 40 score: -10.054429101018437
Market cap: 32784830464 (Large Cap ($10B-$200B))
P/E ratio: 0.09426698351273013
Debt to equity: 0.0998
Free cash flow (dilution adjusted): 5494913.098770666
Operating income: 28489826.19754133
Net income: 19419245.442984316
Long score: 9 | Short score: 2
Recommendation: Long
Stock screener scorecard for HAUTO.OL (quarterly, report date 2026-03-31)
Altman Z-score: 16.4510928458395 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 5.215839157994972%
Earnings yield: 0.03931086679765847%
Return on net tangible assets: 4.927189838252651%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.1936201583520125%
Free cash flow margin: 20.344440554972138%
Revenue growth: 3.7488196371085922%
Rule of 40 score: 24.09326019208073
Market cap: 28996931584 (Large Cap ($10B-$200B))
P/E ratio: 0.5700723662601582
Debt to equity: 0.7578
Free cash flow (dilution adjusted): 7526104.830421377
Operating income: 11664337.101747174
Net income: 10548509.763617678
Long score: 5 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for IBAB.BR (annual, report date 2025-12-31)
Altman Z-score: 1.6007249930862377 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 39.06560811167636%
Earnings yield: 4.830132729052504%
Return on net tangible assets: 20.402240749771046%
Capitalized R&D asset: 132011344.48529412
ROCI (R&D adjusted): 9.415202859923944%
Rosenberg metric: 0.9689896671977003
Free cash flow margin: -6.186963357116943%
Revenue growth: 40.60485774092718%
Rule of 40 score: 34.417894383810236
Market cap: 483229120 (Small Cap ($300M-$2B))
P/E ratio: 35.65826330532213
Debt to equity: 0.9192
Free cash flow (dilution adjusted): -45141176.47058824
Operating income: 26108235.29411765
Net income: 14977647.05882353
Long score: 5 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for IBM.DE (quarterly, report date 2026-06-30)
Altman Z-score: 2.454607972472224 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 220.54263565891472%
Earnings yield: 1.213994790343064%
Return on net tangible assets: -6.114489565812092%
Capitalized R&D asset: 4488620000
ROCI (R&D adjusted): 2.429930199101802%
Rosenberg metric: 0.44040497008743673
Free cash flow margin: 9.998834634657966%
Revenue growth: 7.821825720927309%
Rule of 40 score: 17.820660355585275
Market cap: 177121263616 (Large Cap ($10B-$200B))
P/E ratio: 28.012684989429175
Debt to equity: 1.8897
Free cash flow (dilution adjusted): 1716000000
Operating income: 2845000000
Net income: 2165000000
Long score: 7 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for JEN.DE (quarterly, report date 2026-03-31)
Altman Z-score: 2.4255014300665345 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 3.4448172975500624%
Earnings yield: 1.1512327089466077%
Return on net tangible assets: 9.936381020574588%
Capitalized R&D asset: 37028036.24070318
ROCI (R&D adjusted): 1.7628104687197006%
Rosenberg metric: -0.7639090530179058
Free cash flow margin: 4.025056588755213%
Revenue growth: -19.504031965354276%
Rule of 40 score: -15.478975376599063
Market cap: 2252892160 (Mid Cap ($2B-$10B))
P/E ratio: 24.146573329876414
Debt to equity: 0.3825
Free cash flow (dilution adjusted): 11159770.114942528
Operating income: 29805747.12643678
Net income: 19257471.264367815
Long score: 7 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for JISLJALEQS.NS (annual, report date 2026-03-31)
Altman Z-score: 1.2570722284480451 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 9.00930697638643%
Earnings yield: 0.07582709488532614%
Return on net tangible assets: -1.3647276117620621%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.494044723138188%
Free cash flow margin: 4.165743790812712%
Revenue growth: 1.653877040281496%
Rule of 40 score: 5.819620831094208
Market cap: 22276708352 (Large Cap ($10B-$200B))
Debt to equity: 0.7179000000000001
Free cash flow (dilution adjusted): 28104069.52098347
Operating income: 49652395.08266214
Net income: -2608096.6511233575
Long score: 3 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for JISLJALEQS.NS (quarterly, report date 2026-03-31)
Altman Z-score: 0.8012479226228344 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 3.1895623413583567%
Earnings yield: 0.026845044456221826%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.299084773813138%
Revenue growth: 8.617141430334518%
Rule of 40 score: 8.617141430334518
Market cap: 22276708352 (Large Cap ($10B-$200B))
Debt to equity: 0.7179000000000001
Operating income: 17578423.060618907
Net income: -1272785.0784230607
Long score: 1 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for JKTYRE.NS (annual, report date 2026-03-31)
Altman Z-score: 2.1625165182829544 (Grey Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 15.765403212596388%
Earnings yield: 0.10396505899299814%
Return on net tangible assets: -2.715759259993074%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 14.752154866544927%
Free cash flow margin: 0.12170286004783588%
Revenue growth: 0.7326554000844672%
Rule of 40 score: 0.8543582601323031
Market cap: 112605880320 (Large Cap ($10B-$200B))
P/E ratio: 0.14764071761218484
Debt to equity: 0.8055
Free cash flow (dilution adjusted): 2105765.154726579
Operating income: 165236328.95294616
Net income: 82247774.48071216
Long score: 7 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for JKTYRE.NS (quarterly, report date 2026-03-31)
Altman Z-score: 1.1696878113550369 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 4.1895605784534%
Earnings yield: 0.02762808580408734%
Return on net tangible assets: 5.181013288492782%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.920295957082439%
Revenue growth: -4.853535768730809%
Rule of 40 score: -4.853535768730809
Market cap: 112605880320 (Large Cap ($10B-$200B))
P/E ratio: 0.14764071761218484
Debt to equity: 0.8055
Operating income: 43910555.32005087
Net income: 18862865.62102586
Long score: 1 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for KOVAI.NS (annual, report date 2026-03-31)
Altman Z-score: 6.486093336775879 (Safe Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 19.44412837028175%
Earnings yield: 0.054125082523270744%
Return on net tangible assets: 7.839171283792698%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 18.941721755081513%
Free cash flow margin: 6.936192217967017%
Revenue growth: 4.8433215984248665%
Rule of 40 score: 11.779513816391884
Market cap: 63957520384 (Large Cap ($10B-$200B))
P/E ratio: 0.13850209584232154
Debt to equity: 0.3053
Free cash flow (dilution adjusted): 11644743.535396354
Operating income: 34915324.28995337
Net income: 25907164.052564647
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for KOVAI.NS (quarterly, report date 2026-03-31)
Altman Z-score: 5.523949019207706 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 4.834205461950389%
Earnings yield: 0.013456595460582199%
Return on net tangible assets: 6.772119673953824%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.7092969673617056%
Revenue growth: -3.3249394455905197%
Rule of 40 score: -3.3249394455905197
Market cap: 63957520384 (Large Cap ($10B-$200B))
P/E ratio: 0.13850209584232154
Debt to equity: 0.3053
Operating income: 8680659.177617634
Net income: 6325349.724459517
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for META (quarterly, report date 2026-03-31)
Altman Z-score: 7.017904614985272 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 8.137879995445747%
Earnings yield: 1.508276152382387%
Return on net tangible assets: 6.291879250729675%
Capitalized R&D asset: 34176970000
ROCI (R&D adjusted): 6.24857412346773%
Rosenberg metric: -0.16889407645170704
Free cash flow margin: 12.780806591962493%
Revenue growth: -5.9806655201776495%
Rule of 40 score: 6.800141071784844
Market cap: 1510844137472 (Mega Cap (>= $200B))
P/E ratio: 20.785454545454545
Debt to equity: 0.35609999999999997
Free cash flow (dilution adjusted): 7197000000
Operating income: 22872000000
Net income: 26773000000
Long score: 8 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for MG.TO (quarterly, report date 2026-03-31)
Altman Z-score: 1.660580729101667 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 3.2989077940411624%
Earnings yield: 1.0422229345356735%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.249582003343973%
Free cash flow margin: 4.4119063674019845%
Revenue growth: -5.681848326648397%
Rule of 40 score: -1.2699419592464123
Market cap: 25194383360 (Large Cap ($10B-$200B))
P/E ratio: 16.602765691638307
Debt to equity: 0.546
Free cash flow (dilution adjusted): 329496402.8776979
Operating income: 319424460.4316547
Net income: -719424.4604316547
Long score: 3 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for SRG.AX (annual, report date 2025-06-30)
Altman Z-score: 4.717929462105684 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 39.62327228086328%
Earnings yield: 2.1489281103428115%
Return on net tangible assets: 72.75747508305648%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 14.791090852923789%
Free cash flow margin: 5.022719595679611%
Revenue growth: 21.332605469915947%
Rule of 40 score: 26.355325065595558
Market cap: 2142945408 (Mid Cap ($2B-$10B))
P/E ratio: 12.200435729847493
Debt to equity: 0.4144
Free cash flow (dilution adjusted): 43441830.06535947
Operating income: 47254248.36601307
Net income: 31033986.928104576
Long score: 10 | Short score: 2
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for UNF (quarterly, report date 2026-05-31)
Altman Z-score: 6.691651378737815 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 1.4822032632928468%
Earnings yield: 0.4395820315240946%
Return on net tangible assets: 1.811599503178972%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.912079207920792%
Free cash flow margin: 2.8040579947730304%
Revenue growth: 1.9111493080376865%
Rule of 40 score: 4.715207302810716
Market cap: 5322895360 (Mid Cap ($2B-$10B))
P/E ratio: 41.87361769352291
Debt to equity: 0.0387
Free cash flow (dilution adjusted): 17789000
Operating income: 23030000
Net income: 19916000
Long score: 7 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for VODI.DE (annual, report date 2026-03-31)
Altman Z-score: -0.68122692087208 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 9.983995732195252%
Earnings yield: 6.604677914636977%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.533699007769796%
Free cash flow margin: 17.206692864733945%
Revenue growth: 9.467479114898966%
Rule of 40 score: 26.67417197963291
Market cap: 30891468800 (Large Cap ($10B-$200B))
Debt to equity: 1.0015
Free cash flow (dilution adjusted): 9160526315.789474
Operating income: 4925000000
Net income: -64473684.21052632
Long score: 4 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for WELL.TO (quarterly, report date 2026-03-31)
Altman Z-score: 0.6576570690743092 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 29.53283710984084%
Earnings yield: 0.5587202887632733%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.8408974881385624%
Free cash flow margin: -0.13360089718976484%
Revenue growth: -5.667728623453073%
Rule of 40 score: -5.801329520642837
Market cap: 1011418496 (Small Cap ($300M-$2B))
P/E ratio: 25.11445389143231
Debt to equity: 0.7568
Free cash flow (dilution adjusted): -353956.83453237405
Operating income: 10333093.525179857
Net income: -3832374.100719425
Long score: 3 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for 3776.T (annual, report date 2025-12-31)
Altman Z-score: 2.285537028391519 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 7.73721477439038%
Earnings yield: 0.032266182412837435%
Return on net tangible assets: 5.320453226681973%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.546094543037653%
Free cash flow margin: 2.9055936166385976%
Revenue growth: 14.325393642426917%
Rule of 40 score: 17.230987259065515
Market cap: 11234363679.675814 (Large Cap ($10B-$200B))
P/E ratio: 37.421933058665374
Debt to equity: 0.19589533998530498
Free cash flow (dilution adjusted): 2840342.6890863758
Operating income: 5185601.943609743
Net income: 1919365.769452081
Long score: 6 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for 3922.T (annual, report date 2026-02-28)
Altman Z-score: 12.035800424576328 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 45.181076733136294%
Earnings yield: 0.11316670489099268%
Return on net tangible assets: 29.270054665706425%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 39.05373569212211%
Free cash flow margin: 35.42898361532226%
Revenue growth: 14.80057380751591%
Rule of 40 score: 50.22955742283817
Market cap: 32418310395 (Large Cap ($10B-$200B))
P/E ratio: 13.519222064170025
Debt to equity: 0.00014920278922971473
Free cash flow (dilution adjusted): 21699961.503913768
Operating income: 23244803.02835878
Net income: 15385230.334915949
Long score: 16 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 4013.T (annual, report date 2025-12-31)
Altman Z-score: 5.646543299261267 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 14.795231770355699%
Earnings yield: 0.08920614814318638%
Return on net tangible assets: 21.44564753784009%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.462068123790246%
Free cash flow margin: 22.46430945522459%
Revenue growth: 23.16223288139984%
Rule of 40 score: 45.62654233662443
Market cap: 24250627920.94225 (Large Cap ($10B-$200B))
P/E ratio: 23.937406950988564
Debt to equity: 0.18280479588884788
Free cash flow (dilution adjusted): 7713311.169362573
Operating income: 9726858.896489995
Net income: 6477111.437887603
Long score: 13 | Short score: 0
Recommendation: Long
Stock screener scorecard for 4967.T (annual, report date 2025-12-31)
Altman Z-score: 5.94919829395752 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 9.566164690804229%
Earnings yield: 0.02806800261698532%
Return on net tangible assets: 0.9174264534958803%
Capitalized R&D asset: 118205479.01504335
ROCI (R&D adjusted): 6.275657415928501%
Rosenberg metric: -0.2830030115908466
Free cash flow margin: 6.986159211304317%
Revenue growth: 0.45688704621541804%
Rule of 40 score: 7.443046257519735
Market cap: 401283237515.91516 (Mega Cap (>= $200B))
P/E ratio: 109.64022882948504
Debt to equity: 0.0032131483166515013
Free cash flow (dilution adjusted): 74029793.49146475
Operating income: 95441467.93683268
Net income: 23400038.360718623
Long score: 6 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 4979.T (annual, report date 2025-12-31)
Altman Z-score: 2.637144104776375 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 28.580896363184493%
Earnings yield: 0.06992212700554915%
Return on net tangible assets: 40.217610316340924%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 15.166835187057634%
Free cash flow margin: 13.442879499217527%
Revenue growth: 7.709928725592389%
Rule of 40 score: 21.152808224809917
Market cap: 21574019040.480236 (Large Cap ($10B-$200B))
P/E ratio: 8.77349289974796
Debt to equity: 0.4597574421168688
Free cash flow (dilution adjusted): 27459881.081772264
Operating income: 22057413.208874114
Net income: 15721501.182788825
Long score: 10 | Short score: 1
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 5943.T (annual, report date 2025-12-31)
Altman Z-score: 2.1240801155868567 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 4.566011295596416%
Earnings yield: 0.0303044162365729%
Return on net tangible assets: 4.221460250625015%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.5885624179977618%
Free cash flow margin: 1.8579651470682852%
Revenue growth: 0.29388076774167904%
Rule of 40 score: 2.1518459148099645
Market cap: 89535983714.44029 (Large Cap ($10B-$200B))
P/E ratio: 24.78161741335186
Debt to equity: 0.04325401476966358
Free cash flow (dilution adjusted): 24001022.952496644
Operating income: 27498241.800396394
Net income: 23099546.064829614
Long score: 5 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for AFK.OL (annual, report date 2025-12-31)
Altman Z-score: 2.8811356916439212 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 6.804849432929213%
Earnings yield: 0.17379626019582542%
Return on net tangible assets: -0.34991252186953203%
Capitalized R&D asset: 764706.6570486755
ROCI (R&D adjusted): 2.609646803628085%
Rosenberg metric: 5.6605422061101764
Free cash flow margin: -1.511879049676026%
Revenue growth: -3.316665111580338%
Rule of 40 score: -4.828544161256364
Market cap: 7312796273.012003 (Mid Cap ($2B-$10B))
Debt to equity: 0.3295366795366795
Free cash flow (dilution adjusted): -5572139.3034825865
Operating income: 17313432.835820895
Net income: -5572139.3034825865
Long score: 3 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for BE (annual, report date 2025-12-31)
Altman Z-score: 4.208312973348291 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 2.0145647926286663%
Earnings yield: 0.1371584694801839%
Return on net tangible assets: -12.125556664294516%
Capitalized R&D asset: 337009880
ROCI (R&D adjusted): 2.318781264308376%
Rosenberg metric: 1.2295850742452685
Free cash flow margin: -4.062067377670092%
Revenue growth: 37.326441660515%
Rule of 40 score: 33.26437428284491
Market cap: 24715327690.52 (Large Cap ($10B-$200B))
Debt to equity: 3.7731293893914346
Free cash flow (dilution adjusted): -82216000
Operating income: 72802000
Net income: -87140000
Long score: 2 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for HAUTO.OL (annual, report date 2025-12-31)
Altman Z-score: 11.743273487903828 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 22.89528469359997%
Earnings yield: 0.16426169853860023%
Return on net tangible assets: 36.437459111168984%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 22.816526406448915%
Free cash flow margin: 21.095017088596943%
Revenue growth: 17.233507578170368%
Rule of 40 score: 38.32852466676731
Market cap: 17453679768.74104 (Large Cap ($10B-$200B))
P/E ratio: 33.991029367785316
Debt to equity: 0.7291343412838741
Free cash flow (dilution adjusted): 29921592.039800994
Operating income: 48739800.995024875
Net income: 51092437.81094527
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for IBM.DE (annual, report date 2025-12-31)
Altman Z-score: 3.5690670427431646 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 170.79573420836752%
Earnings yield: 5.3304825732743595%
Return on net tangible assets: -31.520265180051226%
Capitalized R&D asset: 15562680000
ROCI (R&D adjusted): 10.315409151668248%
Rosenberg metric: 0.5008691001470785
Free cash flow margin: 14.421937929400617%
Revenue growth: 7.621946361130146%
Rule of 40 score: 22.043884290530762
Market cap: 284302907100 (Mega Cap (>= $200B))
P/E ratio: 26.838752676295663
Debt to equity: 1.9732750985003513
Free cash flow (dilution adjusted): 9740000000
Operating income: 12492000000
Net income: 10593000000
Long score: 10 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for JEN.DE (annual, report date 2025-12-31)
Altman Z-score: 1.990345925817039 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 17.584031525526942%
Earnings yield: 5.065037935306969%
Return on net tangible assets: 45.21069109566589%
Capitalized R&D asset: 139808210.90686274
ROCI (R&D adjusted): 7.910504126078921%
Rosenberg metric: 0.1036487806312245
Free cash flow margin: 11.584333438817255%
Revenue growth: 5.874527285647347%
Rule of 40 score: 17.458860724464603
Market cap: 1109847049.8500001 (Small Cap ($300M-$2B))
P/E ratio: 14.950656705148583
Debt to equity: 0.39740520365823095
Free cash flow (dilution adjusted): 142551764.70588237
Operating income: 131135294.11764707
Net income: 87334117.64705883
Long score: 9 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for META (annual, report date 2025-12-31)
Altman Z-score: 7.818173119789893 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 31.581023171147937%
Earnings yield: 5.491570691928807%
Return on net tangible assets: 4.964103757863049%
Capitalized R&D asset: 99466300000
ROCI (R&D adjusted): 22.205054014941062%
Rosenberg metric: 0.6940715246279032
Free cash flow margin: 12.779276096454126%
Revenue growth: 22.16703849824621%
Rule of 40 score: 34.94631459470034
Market cap: 1446996398389.0798 (Mega Cap (>= $200B))
P/E ratio: 23.93391111828178
Debt to equity: 0.38618965858508675
Free cash flow (dilution adjusted): 25682000000
Operating income: 83276000000
Net income: 60458000000
Long score: 11 | Short score: 2
Recommendation: Long
Stock screener scorecard for MG.TO (annual, report date 2025-12-31)
Altman Z-score: 2.7323166647679455 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 14.875916525662717%
Earnings yield: 5.02521148928072%
Return on net tangible assets: 17.026656832788962%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.328960250636381%
Free cash flow margin: 5.43918114734587%
Revenue growth: 2.3668270020509343%
Rule of 40 score: 7.8060081493968045
Market cap: 19611056582 (Large Cap ($10B-$200B))
P/E ratio: 22.209577103057757
Debt to equity: 0.5209907313653711
Free cash flow (dilution adjusted): 1667883211.678832
Operating income: 1540145985.4014597
Net income: 644525547.4452554
Long score: 9 | Short score: 1
Recommendation: Long
Stock screener scorecard for RHLD (annual, report date 2025-12-31)
Altman Z-score: 7.544698567845877 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 56.87499007479634%
Earnings yield: 2.283280668309231%
Return on net tangible assets: 2093.1779855894524%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 55.98504033014444%
Free cash flow margin: 34.82767203038599%
Revenue growth: 9.863732877445187%
Rule of 40 score: 44.69140490783118
Market cap: 1704583752.06 (Small Cap ($300M-$2B))
P/E ratio: 12.719065737885956
Debt to equity: 2.512164699225883
Free cash flow (dilution adjusted): 160923000
Operating income: 143259000
Net income: 134018000
Long score: 10 | Short score: 2
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for TRVG (annual, report date 2025-12-31)
Altman Z-score: -0.7549562154119978 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0.9327732629384186%
Earnings yield: 0.6347709588393069%
Return on net tangible assets: 13.675786517302182%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.5840898505798905%
Free cash flow margin: -0.8403897163844114%
Revenue growth: 34.52295016116674%
Rule of 40 score: 33.682560444782325
Market cap: 57202028.31499999 (Micro Cap ($50M-$300M))
P/E ratio: 5.098219992424243
Debt to equity: 0.17038054561906057
Free cash flow (dilution adjusted): -5427058.823529412
Operating income: 1800000
Net income: 13200000
Long score: 4 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for UNF (annual, report date 2025-08-31)
Altman Z-score: 4.944749050563602 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 12.027782196342471%
Earnings yield: 3.5215807925372293%
Return on net tangible assets: 9.554782336449929%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.416253710176898%
Free cash flow margin: 5.359174987830709%
Revenue growth: 0.20272460885602928%
Rule of 40 score: 5.561899596686739
Market cap: 2566802210.96 (Mid Cap ($2B-$10B))
P/E ratio: 17.311559313419348
Debt to equity: 0.03339808027545037
Free cash flow (dilution adjusted): 130354000
Operating income: 184498000
Net income: 148271000
Long score: 7 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for WELL.TO (annual, report date 2025-12-31)
Altman Z-score: 1.373196495488835 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 70.47183939064531%
Earnings yield: 3.6588674200904983%
Return on net tangible assets: -10.280877777761539%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.329643985185884%
Free cash flow margin: 5.094134392816918%
Revenue growth: 58.91266473295257%
Rule of 40 score: 64.00679912576949
Market cap: 1019080732.9500002 (Small Cap ($300M-$2B))
P/E ratio: 228.39102038323622
Debt to equity: 0.5778787336515945
Free cash flow (dilution adjusted): 52063503.649635024
Operating income: 67667883.21167883
Net income: 3256934.306569343
Long score: 7 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 0386.HK (annual, report date 2025-12-31)
Altman Z-score: 1.7854819753268005 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 4.955328620354145%
Earnings yield: 0.6828675730064374%
Return on net tangible assets: 18.31222306482242%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.6089659173074753%
Free cash flow margin: 1.0378710970640086%
Revenue growth: -5.601370637487184%
Rule of 40 score: -4.563499540423176
Market cap: 515662151680 (Mega Cap (>= $200B))
P/E ratio: 1.8741189153329463
Debt to equity: 0.5795
Free cash flow (dilution adjusted): 4124428571.428571
Operating income: 7501142857.142858
Net income: 5115714285.714286
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2661.HK (annual, report date 2025-12-31)
Altman Z-score: 4.324177886437704 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 7.498482860131393%
Earnings yield: 3.624575051041516%
Return on net tangible assets: -38.27192537808694%
Capitalized R&D asset: 20259322.12093438
ROCI (R&D adjusted): 7.034689768509529%
Rosenberg metric: 1.2794395340489713
Free cash flow margin: 5.501529994338663%
Revenue growth: 38.59284793656638%
Rule of 40 score: 44.09437793090504
Market cap: 1218021888 (Small Cap ($300M-$2B))
Debt to equity: 0.0034000000000000002
Free cash flow (dilution adjusted): 9870428.57142857
Operating income: 10538142.857142856
Net income: -54245857.14285714
Long score: 9 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 3291.T (annual, report date 2026-03-31)
Altman Z-score: 2.2239612618332103 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 9.601997586385341%
Earnings yield: 0.0609556489306791%
Return on net tangible assets: 8.298977620257853%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.900129171025944%
Free cash flow margin: -7.923643217678995%
Revenue growth: -3.2371129548582243%
Rule of 40 score: -11.16075617253722
Market cap: 623677341696 (Mega Cap (>= $200B))
P/E ratio: 0.06532351898801765
Debt to equity: 0.7652
Free cash flow (dilution adjusted): -747979229.2292292
Operating income: 590865865.8658658
Net income: 396114864.8648649
Long score: 2 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 3934.T (annual, report date 2026-03-31)
Altman Z-score: 4.493889437768786 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 16.60152268001002%
Earnings yield: 0.08154162701573833%
Return on net tangible assets: 13.193363602476706%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 14.943036479460936%
Free cash flow margin: -2.818892876731975%
Revenue growth: 35.0939311594248%
Rule of 40 score: 32.275038282692826
Market cap: 12805441536 (Large Cap ($10B-$200B))
P/E ratio: 0.06718944705498137
Debt to equity: 0.23550000000000001
Free cash flow (dilution adjusted): -3243906.4064064063
Operating income: 9271771.771771772
Net income: 6226295.045045045
Long score: 6 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 4828.T (annual, report date 2026-03-31)
Altman Z-score: 11.507380053680086 (Safe Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 52.1108772780773%
Earnings yield: 0.06882657388509598%
Return on net tangible assets: 41.550003297330306%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 39.75194511669461%
Free cash flow margin: 19.414426078013168%
Revenue growth: 10.121718612880072%
Rule of 40 score: 29.536144690893238
Market cap: 70323372032 (Large Cap ($10B-$200B))
P/E ratio: 0.09038004027004272
Debt to equity: 0.0062
Free cash flow (dilution adjusted): 29688526.026026025
Operating income: 40113788.78878879
Net income: 30598023.023023024
Long score: 15 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 6806.T (annual, report date 2026-03-31)
Altman Z-score: 13.04119867035748 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 14.463574465794714%
Earnings yield: 0.03174002820376563%
Return on net tangible assets: 8.798822719356277%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.792567825371005%
Free cash flow margin: 12.238715540745229%
Revenue growth: 4.400804563406195%
Rule of 40 score: 16.639520104151423
Market cap: 927327584256 (Mega Cap (>= $200B))
P/E ratio: 0.1272191639164116
Debt to equity: 0.019799999999999998
Free cash flow (dilution adjusted): 161761761.76176175
Operating income: 268987737.7377377
Net income: 207344844.84484485
Long score: 7 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for 6863.T (annual, report date 2026-03-31)
Altman Z-score: 5.4967443605151765 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 10.872676786384883%
Earnings yield: 0.06868676194364837%
Return on net tangible assets: 10.193070934887814%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 9.264050622351416%
Free cash flow margin: 16.887999836704704%
Revenue growth: -4.079215607305802%
Rule of 40 score: 12.808784229398903
Market cap: 20055699456 (Large Cap ($10B-$200B))
P/E ratio: 0.06382091219636346
Debt to equity: 0.032
Free cash flow (dilution adjusted): 11646396.396396397
Operating income: 10643493.493493494
Net income: 9019062.812812813
Long score: 8 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 8118.T (annual, report date 2026-03-31)
Altman Z-score: 4.81833592524428 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 4.1413294191654435%
Earnings yield: 0.04894063225795743%
Return on net tangible assets: 2.4188247666622846%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.163416489808994%
Free cash flow margin: 9.036375239310786%
Revenue growth: -10.089022760654496%
Rule of 40 score: -1.0526475213437099
Market cap: 19545853952 (Large Cap ($10B-$200B))
P/E ratio: 0.1836405569466168
Debt to equity: 0.016399999999999998
Free cash flow (dilution adjusted): 4429429.42942943
Operating income: 4942442.442442442
Net income: 3910160.16016016
Long score: 7 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for APPN (quarterly, report date 2026-03-31)
Altman Z-score: 0.5974610141062179 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 2.907121341918369%
Earnings yield: 0.17219913158210118%
Capitalized R&D asset: 94491660
ROCI (R&D adjusted): 1.0355603952211172%
Rosenberg metric: 0.31441962313440003
Free cash flow margin: 18.17687209417351%
Revenue growth: -0.3386455165206761%
Rule of 40 score: 17.838226577652836
Market cap: 1743537792 (Small Cap ($300M-$2B))
P/E ratio: 1205.5
Debt to equity: -5.006393406481592
Free cash flow (dilution adjusted): 36750000
Operating income: 3156000
Net income: -1525000
Long score: 4 | Short score: 8
Recommendation: Neutral
Stock screener scorecard for ATH.TO (quarterly, report date 2026-03-31)
Altman Z-score: 4.824069645401489 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 4.312072834482896%
Earnings yield: 1.2214203155341223%
Return on net tangible assets: -1.7964101031624355%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.851843802041259%
Free cash flow margin: -3.3726408547556384%
Revenue growth: 29.74712407545827%
Rule of 40 score: 26.374483220702633
Market cap: 5304640000 (Mid Cap ($2B-$10B))
P/E ratio: 17.98561151079137
Debt to equity: 0.10869999999999999
Free cash flow (dilution adjusted): -9615107.913669065
Operating income: 65279136.69064749
Net income: 33298561.15107914
Long score: 5 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for BIOCON.NS (annual, report date 2026-03-31)
Altman Z-score: 2.2867504626930324 (Grey Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 9.650484457570034%
Earnings yield: 0.02163112418575245%
Return on net tangible assets: 10.423727190916571%
Capitalized R&D asset: 152939165.73289248
ROCI (R&D adjusted): 3.317237361728019%
Rosenberg metric: 0.30713710452956616
Free cash flow margin: -0.4862961042676059%
Revenue growth: 1.0580006503185073%
Rule of 40 score: 0.5717045460509014
Market cap: 706109571072 (Mega Cap (>= $200B))
P/E ratio: 1.3486625990161616
Debt to equity: 0.4215
Free cash flow (dilution adjusted): -8647732.089868588
Operating income: 182503179.31326833
Net income: 40864773.208986856
Long score: 6 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for BIOCON.NS (quarterly, report date 2026-03-31)
Altman Z-score: 2.030574401509006 (Grey Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 2.8406193435585916%
Earnings yield: 0.006367119708354868%
Return on net tangible assets: 13.632795297451509%
Capitalized R&D asset: -5810728.5620954465
ROCI (R&D adjusted): 1.053277960641899%
Revenue growth: 2.232638013788342%
Rule of 40 score: 2.232638013788342
Market cap: 706109571072 (Mega Cap (>= $200B))
P/E ratio: 1.3486625990161616
Debt to equity: 0.4215
Operating income: 53719796.52395083
Net income: 21047053.836371344
Long score: 4 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for BTI (annual, report date 2025-12-31)
Altman Z-score: 1.871094375069237 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 441.1275066212636%
Earnings yield: 2.270629850836485%
Return on net tangible assets: -24.407813781788352%
Capitalized R&D asset: 401062324.66643864
ROCI (R&D adjusted): 12.2419112396021%
Rosenberg metric: 9.694470332401371
Free cash flow margin: 22.014837953924246%
Revenue growth: 7.034006597156559%
Rule of 40 score: 29.048844551080805
Market cap: 131524968448 (Large Cap ($10B-$200B))
P/E ratio: 11.950749464668094
Debt to equity: 0.7284
Free cash flow (dilution adjusted): 7618918918.918919
Operating income: 15755405405.405405
Net income: 10493243243.243244
Long score: 8 | Short score: 3
Recommendation: Long
Stock screener scorecard for CLN.SW (annual, report date 2025-12-31)
Altman Z-score: 2.1091900485551123 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 12.969140950792326%
Earnings yield: 9.807685970845244%
Capitalized R&D asset: 314884990.95840865
ROCI (R&D adjusted): 6.459089821083105%
Rosenberg metric: 0.6046815350612811
Free cash flow margin: 6.973180076628352%
Revenue growth: 7.421160459501%
Rule of 40 score: 14.394340536129352
Market cap: 2441901824 (Mid Cap ($2B-$10B))
Debt to equity: 0.9308
Free cash flow (dilution adjusted): 345569620.2531645
Operating income: 393670886.0759494
Net income: -51898734.17721519
Long score: 7 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CSL (quarterly, report date 2026-03-31)
Altman Z-score: 4.176133396840991 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 8.033327392621636%
Earnings yield: 1.149584161424988%
Return on net tangible assets: -11.633004540472836%
Capitalized R&D asset: 24835000
ROCI (R&D adjusted): 3.3239520052858103%
Rosenberg metric: -1.3488372093023255
Free cash flow margin: -7.746411938028705%
Revenue growth: -6.70391061452514%
Rule of 40 score: -14.450322552553844
Market cap: 13597884416 (Large Cap ($10B-$200B))
P/E ratio: 19.399649941656943
Debt to equity: 1.7472999999999999
Free cash flow (dilution adjusted): -81500000
Operating income: 180300000
Net income: 127700000
Long score: 2 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for CTO.DE (quarterly, report date 2026-05-31)
Altman Z-score: 5.5107416800822016 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 7.021350892946224%
Earnings yield: 0.7786339051450376%
Return on net tangible assets: 4.106359485511355%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.3536846857013884%
Free cash flow margin: 2.718107958654133%
Revenue growth: 1.336264494159231%
Rule of 40 score: 4.054372452813364
Market cap: 363031756800 (Mega Cap (>= $200B))
P/E ratio: 56.476690847023676
Debt to equity: 0.6026
Free cash flow (dilution adjusted): 1917000000
Operating income: 2815000000
Net income: 2192000000
Long score: 7 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for GF.SW (annual, report date 2025-12-31)
Altman Z-score: 2.06265407906318 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 21.488528259653048%
Earnings yield: 8.214566024225025%
Return on net tangible assets: -147.6190476190477%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 18.595641646489106%
Free cash flow margin: -0.3001000333444482%
Revenue growth: 11.982375564766057%
Rule of 40 score: 11.68227553142161
Market cap: 3540412928 (Mid Cap ($2B-$10B))
P/E ratio: 27.525025157565803
Debt to equity: 55.0976
Free cash flow (dilution adjusted): -11392405.06329114
Operating income: 486075949.36708856
Net income: 137974683.5443038
Long score: 6 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for HFFG (quarterly, report date 2026-03-31)
Altman Z-score: -0.2456545292690414 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0.4716509146480129%
Earnings yield: 0.35170629852868607%
Return on net tangible assets: -3.9939431727086485%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.277700415613351%
Free cash flow margin: -0.11217876808481995%
Revenue growth: 1.2917866522954453%
Rule of 40 score: 1.1796078842106255
Market cap: 83154272 (Micro Cap ($50M-$300M))
P/E ratio: 18.23921855641593
Debt to equity: 1.0834000000000001
Free cash flow (dilution adjusted): -350000
Operating income: 1037000
Net income: 1356000
Long score: 1 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for HMR (quarterly, report date 2026-03-31)
Altman Z-score: 1.000008810862466 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 65.77568678878771%
Earnings yield: 8.027596410487632%
Return on net tangible assets: 19.63611116869798%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.303856433732596%
Rule of 40 score: 0
Market cap: 67840792 (Micro Cap ($50M-$300M))
P/E ratio: 3.8703905468472253
Debt to equity: 0
Operating income: 3200793.103448276
Net income: 3200793.103448276
Long score: 7 | Short score: 4
Recommendation: Neutral